Banque Cantonale Vaudoise Catalent, Inc. Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$87.2 - $114.05 $26,160 - $34,215	-300 Reduced 11.11%	2,400 $258,000
Q1 2021 May 11, 2021	SELL	$101.51 - $125.27 $416,191 - $513,607	-4,100 Reduced 60.29%	2,700 $285,000
Q4 2020 Feb 05, 2021	BUY	$85.88 - $105.36 $352,108 - $431,976	4,100 Added 151.85%	6,800 $708,000
Q3 2020 Oct 30, 2020	BUY	$72.74 - $92.5 $196,398 - $249,750	2,700 New	2,700 $231,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.